Considering that tryptophan-derived uremic toxin are ligands for AHR and that AHR activation is associated with hypertension programming [172,179], AHR antagonists might provide a potential reprogramming strategy to prevent tryptophan metabolites-induced adverse outcomes. Here, AHR is linked to hypertensive disorder.